qRT-PCR and western blotting showed that CCL2 and CXCL10 reversed PD-L1 expression in TAMs, which decreased in ALKBH5-knockdown NSCLC cells (Fig. 6B and C). Here, CXCL10 is linked to non-small cell lung carcinoma.